Recombinant Human AGL protein, GST-tagged
Cat.No. : | AGL-301513H |
Product Overview : | Recombinant Human AGL (258-424 aa) protein, fused to GST tag, was expressed in E. coli. |
- Specification
- Gene Information
- Related Products
- Download
Source : | E. coli |
Species : | Human |
Tag : | GST |
Form : | The purified protein was Lyophilized from sterile PBS (58mM Na2HPO4,17mM NaH2PO4, 68mM NaCl, pH8.). 5 % trehalose and 5 % mannitol are added as protectant before lyophilization. |
Protein length : | Ser258-Pro424 |
AA Sequence : | SCDVAEGKYKEKGIPALIENDHHMN SIRKIIWEDIFPKLKLWEFFQVDVN KAVEQFRRLLTQENRRVTKSDPNQH LTIIQDPEYRRFGCTVDMNIALTTF IPHDKGPAAIEECCNWFHKRMEELN SEKHRLINYHQEQAVNCLLGNVFYE RLAGHGPKLGPVTRKHP |
Purity : | 90%, by SDS-PAGE with Coomassie Brilliant Blue staining. |
Stability : | Store for up to 12 months at -20°C to -80°C as lyophilized powder. |
Storage : | Short-term storage: Store at 2-8°C for (1-2 weeks). Long-term storage: Aliquot and store at -20°C to -80°C for up to 3 months, buffer containing 50% glycerol is recommended for reconstitution. Avoid repeat freeze-thaw cycles. |
Gene Name : | AGL amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase [ Homo sapiens ] |
Official Symbol : | AGL |
Synonyms : | AGL; amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase; amylo 1, 6 glucosidase, 4 alpha glucanotransferase; glycogen debranching enzyme; glycogen storage disease type III; glycogen debrancher; amylo-1, 6-glucosidase, 4-alpha-glucanotransferase; GDE; |
Gene ID : | 178 |
mRNA Refseq : | NM_000028 |
Protein Refseq : | NP_000019 |
MIM : | 610860 |
UniProt ID : | P35573 |
Products Types
◆ Recombinant Protein | ||
AGL-2739H | Recombinant Human AGL protein(731-830 aa), C-His-tagged | +Inquiry |
AGL-290H | Recombinant Human AGL Protein, His (Fc)-Avi-tagged | +Inquiry |
AGL-527H | Recombinant Human AGL Protein, MYC/DDK-tagged | +Inquiry |
Agl-93M | Recombinant Mouse Agl Protein, His-tagged | +Inquiry |
Agl-1554M | Recombinant Mouse Agl Protein, Myc/DDK-tagged | +Inquiry |
◆ Lysates | ||
AGL-8980HCL | Recombinant Human AGL 293 Cell Lysate | +Inquiry |
AGL-8979HCL | Recombinant Human AGL 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (20)
Ask a questionYes, AGL mutations can cause low blood sugar levels due to impaired glucose release.
AGL mutations might contribute to cardiomyopathy due to glycogen accumulation.
Yes, AGL mutations can lead to muscle weakness due to impaired glycogen breakdown.
Research explores whether AGL's function is conserved in different organisms.
AGL activity ensures proper glycogen breakdown, maintaining cellular glycogen levels.
Yes, ongoing research uncovers AGL's roles in metabolism and related diseases.
AGL's enzymatic activity alters glycogen structure by removing branches.
AGL's role in glycogen metabolism makes it a potential therapeutic target.
AGL's enzymatic role is in breaking down glycogen, not synthesizing it.
AGL dysfunction can affect various tissues due to glycogen storage disruptions.
AGL deficiency affects muscle cells due to impaired glycogen breakdown.
Research on AGL provides insights into glycogen metabolism and related diseases.
Yes, hormones regulate AGL activity to maintain glucose levels.
Yes, AGL's role in glycogen breakdown can impact heart function and health.
AGL's role in glycogen breakdown helps maintain glucose homeostasis.
Yes, AGL deficiency is usually inherited in an autosomal recessive manner.
AGL deficiency hinders glucose release from glycogen, affecting energy supply.
Yes, AGL mutations can impact exercise tolerance due to limited energy supply.
Yes, AGL mutations can impact multiple organs due to glycogen storage issues.
AGL mutations can impact brain health due to glycogen storage issues in certain tissues.
Customer Reviews (5)
Write a reviewNotable improvements in cell proliferation were attributed to the protein product’s efficacy.
We observed a significant enhancement in enzyme activity using the protein product.
The protein product’s compatibility with various assays broadened the scope of our investigations.
Reliable protein-protein interaction studies were enabled by the protein product’s pure composition.
Minimal background noise in our assays indicated the protein product’s quality.
Ask a Question for All AGL Products
Required fields are marked with *
My Review for All AGL Products
Required fields are marked with *
Inquiry Basket